Ipca Labs buys 13.09 percent stake in Trophic Wellness for Rs 21.20 crore
New Delhi: Drug firm Ipca Laboratories on Friday said it has acquired an additional 13.09 per cent stake in Trophic Wellness Pvt Ltd for a cash consideration of Rs 21.20 crore, making it a subsidiary of the company.
The company has acquired further 13.09 per cent of the equity share capital of Trophic Wellness Pvt Ltd.
The company now holds 52.35 per cent of the paid-up equity share capital of Trophic Wellness Pvt Ltd (TWPL), Ipca Labs said in a regulatory filing.
"With the acquisition of these further shares, TWPL has now become the company's subsidiary. This will help the company to grow its nutraceuticals portfolio and business," it added.
The acquisition of the shares is for cash consideration of Rs 21.20 crore for 5,30,000 equity shares of TWPL, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.